European VC Funds

AdTay Ventures, also operating as Three Sixty Capital, is a London-based venture capital fund founded in 2020 by partners Dan Adler and Doron Tay. The firm focuses on early-stage technology companies with the potential to become market leaders in their respective fields, with primary investments in the United Kingdom, Israel, and Central Europe, and selective exposure to US-based technology companies as well. AdTay targets seed and Series A rounds, deploying initial checks of $500,000 to $3 million into software, SaaS, and AI companies. The firm serves as a gateway for high-net-worth individuals, ultra-high-net-worth investors, and family offices seeking access to leading scale-up businesses across Europe and Israel. To date, the fund has made 8 investments in technology companies across these geographies. The firm's approach centers on bridging private capital with promising technology startups, prioritising companies with strong market positioning and durable competitive advantages. With two partners drawing on complementary investment and entrepreneurial backgrounds, AdTay seeks to be a reliable early partner to founders building businesses with the ambition and fundamentals to achieve meaningful scale in their categories across the UK, European, and Israeli tech ecosystems.

Advance Venture Partners (AVP), formerly Advance Vixeid Capital Management, is a San Francisco-based evergreen venture capital firm founded in 2015 by David ibnAle, previously a Managing Director at TPG Growth. The firm is built in partnership with Advance, a family-owned multi-generational holding company that owns enduring media and technology businesses. AVP concentrates on digital health, data platforms, robotics, enterprise software, consumer technology, and B2B marketplace-based businesses across the US and Europe. AVP leads Series A, B, and C rounds with initial checks of $10 million to $25 million, and can deploy $50 million to $75 million of total capital over the life of an investment. The firm has made 74 investments to date. Notable portfolio companies include Compass, Curology, Farfetch, Rent the Runway, Vestiaire Collective, Midi Health, GrayMatter Robotics, Tegus, and Affinity. AVP writes checks into businesses with product in market, evidence of product-market fit, sound fundamentals, and large addressable end markets. The partnership team includes Alex Christ, Venture Partner Gina Sanders (also Managing Partner at Advance Publications), and Vice President Ameen Dalli. AVP takes an active ownership posture — working directly with founders on strategy, market development, and team building — reflecting the operational depth that comes from Advance's long history as a builder of media and technology companies.

Advent Venture Partners is one of Europe's most established venture and growth capital investors, founded in 1981 and headquartered in London, United Kingdom. With over EUR 500 million in fund commitments under management and 151 investments over its history, the firm has backed innovative businesses across the United Kingdom, continental Europe, and the United States for more than four decades. Advent invests across two core practices: technology and growth capital, and life sciences through its dedicated Advent Life Sciences arm. The firm focuses on early and mid-stage companies across enterprise software, healthcare, drug discovery and development, diagnostics, consumer, and media, deploying initial checks of $3 million to $10 million and leading rounds. Advent's portfolio carries a strong exit track record spanning 2 IPOs and 21 acquisitions, with notable companies including Yelp, Wiz, and Farfetch. The current active portfolio comprises 28 companies. Advent's longevity reflects a consistent thesis: back founders with differentiated technology at a stage when capital and strategic guidance make the biggest difference, then support companies through successive growth phases. The firm's dual structure — one arm focused on technology and growth capital, the other on life sciences — allows it to maintain genuine sector depth in two complex, high-conviction verticals while operating with the speed and conviction of a specialist investor.

AENU is a venture capital fund that’s making waves by focusing on early-stage climate tech companies, aligning profitability with environmental and social impact. Based in Europe, AENU primarily invests in startups that tackle the climate crisis through innovations in energy transition, carbon economy, and sustainability. Their portfolio includes impactful companies such as Alcemy, Monta, Ocell, Trawa, and Hometree, which work on solutions ranging from low-carbon cement to intelligent energy management. With a geographic focus on Europe, especially the DACH region, Nordics, and the UK, AENU targets Seed and Series A investments, typically writing checks between €1-4 million. They often co-lead or lead rounds and always aim for board representation to ensure a strategic partnership. Their innovative Impact-as-a-Service (IaaS) offering helps portfolio companies scale while maintaining strong environmental, social, and governance (ESG) standards. Founded by Fabian Heilemann and Ferry Heilemann, AENU boasts a team of seasoned entrepreneurs and investors with a proven track record of scaling ventures. The fund is committed to systemic transformation within venture capital, pushing for stakeholder alignment and equitable growth. Startups looking to partner with AENU should expect a research-driven, high-impact approach, where both financial returns and climate outcomes are equally prioritized​.

Aera VC is a venture capital firm focused on investing in climate tech and frontier technologies that aim to advance humanity and create a sustainable future. Founded in 2016 by Derek Handley and Nick Winstone, Aera VC operates from New York, Singapore, and New Zealand. The firm invests globally, targeting early-stage companies that drive transformational change across various industries. Notable investments include Solugen, which transforms chemicals using plant-based processes, and Twelve, a company that recycles CO₂ into cost-competitive chemicals and fuels. Other significant investments are Shiok Meats, a Singapore-based company developing cell-based seafood, and Carbon Chain, which offers solutions to reduce greenhouse gas emissions in supply chains. Aera VC also supports startups like AstroForge, focused on space technology, and Paloma Health, an online medical practice specializing in hypothyroidism. Aera VC recently raised $42 million in the first close of its new climate-focused fund, which will be used to back up to 30 new seed investments over the next two years. The firm aims to support breakthrough technologies that can significantly reduce the world's carbon footprint and advance sustainable practices across various sectors.

Aescuvest is a prominent pan-European venture capital firm that specializes in health technology. Headquartered in Frankfurt, Germany, Aescuvest collaborates with EIT Health, giving it exclusive access to some of the most promising healthtech startups across Europe. The firm focuses on early to late-stage ventures, investing in areas such as remote monitoring, diagnostics, personalized medicine, and AI in healthcare. Notable investments include startups like Neteera and Caresyntax, showcasing their commitment to advancing healthcare technology. Aescuvest's strategy emphasizes a rigorous selection process and thorough due diligence to ensure exponential growth potential for their investments. They prefer to lead funding rounds and remain actively involved in the growth of their portfolio companies. Aescuvest targets investments primarily within Europe and Israel, fostering a network of healthcare technology-driven investors, including business angels and corporate investors. The fund's typical investment size averages around $2.85 million per round. For startups seeking investment, Aescuvest values innovation that promises substantial improvements in patient outcomes and healthcare delivery. Their approach to building an investment funnel involves leveraging partnerships and a deep understanding of the healthtech sector to identify high-impact opportunities. Key team members include experts deeply rooted in the healthcare industry, such as Helmut Nanz, whose experience and strategic insight drive Aescuvest's mission to transform healthcare through technology.

AFI Ventures is a Paris-based impact seed and pre-seed fund launched in 2020 by Ventech in partnership with Aviva France (now Abeille Assurances) and La Ruche incubator. Classified as an Article 9 fund under EU SFDR — the highest ESG designation — the firm backs entrepreneurs operating at the intersection of commercial viability and positive social or environmental impact. General Partner Audrey Soussan, also a General Partner at Ventech, leads the investment effort alongside Partner Charles Fourault, who brings 20 or more years of investment and advisory experience. AFI leads rounds, investing up to €500,000 per deal in one to two companies per month, with over 42 impact companies in its portfolio across Europe and Africa. The fund covers climate technology, circular economy, water management, renewable energy, sustainable agriculture, health tech, inclusive finance, and education. Portfolio companies include Koolboks (solar cooling), Bon Vivant (precision fermentation, $15.9 million seed), Faircraft (leather alternatives), Morfo (forest restoration), vorteX-io (flood risk management), and Oolu Solar. AFI Ventures is part of Alliance for Impact, a platform that gives founders access to a community of entrepreneurs and business angels extending well beyond the capital itself. The fund is expanding from France into Western Europe, leveraging Ventech's established networks. Its investment thesis centres on renewable energy, sustainable agriculture, and inclusive finance as categories where entrepreneurial solutions can generate measurable societal returns alongside financial ones.

Afore Capital is a San Francisco-based venture capital firm specializing in pre-seed stage investments. Founded in 2016, Afore Capital manages a $300 million fund and typically invests $500,000 to $2 million in early-stage companies that are pre-traction and pre-revenue. The firm focuses on identifying high-potential startups and helping them rapidly scale towards Series A funding rounds. Afore Capital’s diverse portfolio includes companies across sectors such as SaaS, fintech, healthcare, consumer, and enterprise technology. Notable investments include Neo Financial, a digital bank; BetterUp, a platform for professional coaching; and Curefit, a provider of digital and offline fitness services. The firm has a strong track record, with several successful exits and notable co-investments alongside top venture funds like Andreessen Horowitz and Accel​.

AE.no is a prominent force in Norway's aquaculture sector, focusing on sustainable innovations that enhance the efficiency and environmental stewardship of fish farming. As Norway remains a global leader in seafood production, AE.no plays a critical role in supporting the industry’s evolution by developing advanced technologies aimed at minimizing the ecological impact of aquaculture practices. The company’s initiatives are closely aligned with both national and global sustainability objectives, reflecting its commitment to promoting responsible growth within the industry. In addition to its work in traditional fish farming, AE.no is exploring new frontiers within the aquaculture value chain, including emerging sectors like seaweed farming and the development of sustainable feed alternatives. This approach not only helps diversify Norway’s aquaculture offerings but also contributes to the broader goals of environmental sustainability and food security. AE.no collaborates with a range of stakeholders, including government agencies, research institutions, and international organizations, to ensure that its practices are at the forefront of industry standards. The company’s efforts are vital in helping Norway maintain its position as a world leader in seafood production while also addressing the growing global demand for sustainable aquaculture products. By driving innovation and fostering partnerships, AE.no is paving the way for the future of aquaculture, ensuring that it remains a viable and environmentally sound industry for generations to come.

Aglaé Ventures is a global technology-focused venture capital firm headquartered in Paris, with offices in New York and San Francisco. Founded in 2017 and backed by Agache, the principal investment vehicle of Bernard Arnault — controlling shareholder of LVMH, the world's largest luxury goods conglomerate — the firm brings access to patient capital and a formidable global commercial network. Co-founders Cyril Guenoun (General Partner) and Antoine Loison built the firm from the ground up, with Managing Partner Miyuki Matsumoto heading US operations. The portfolio averages 8 new investments per year. Aglaé invests from €100,000 to €100 million across marketplaces, SaaS, consumer apps, digital native brands, fintech, web3, and mobility, at all stages from Seed to Pre-IPO. Across 100 investments, the portfolio has produced 12 unicorns, 7 IPOs, and 16 acquisitions. Notable holdings include Airbnb, Slack, Spotify, Netflix, Lyft, Back Market, Algolia, Databricks, Trade Republic, and eToro, which listed on the NASDAQ in May 2025 at a $2.31 billion valuation. The firm leads rounds and can deploy capital meaningfully at every stage. Aglaé's strategic position — operating from the centre of European luxury with a global reach across France, the US, Israel, and Canada — enables it to bring commercial relationships and brand distribution capabilities to portfolio companies beyond what traditional technology investors can offer. The firm made five AI investments in 2024 across rounds totalling more than $300 million, reflecting continued conviction in foundational AI infrastructure and applications.

Aglaia BioMedical Ventures, now operating as Aglaia Oncology Funds, is a Bilthoven, Netherlands-based venture capital firm founded in 2003 by Karl Rothweiler and Mark Krul, exclusively dedicated to investing in the fight against cancer. The team has been involved in the development of more than 100 oncology products and takes a deeply hands-on, operator-led approach to company building. Partners Folkert van Cleef and Eric van der Putten complete the investment team, alongside Venture Partner Ernst Geutjes. The European Investment Fund (EIF) is among the firm's LPs. Aglaia manages three funds — Oncology Fund I, an Oncology Seed Fund, and Oncology Fund II (which raised $65 million towards an $80 to $100 million target) — and has invested in 12 early-stage companies, six of which were co-founded by Aglaia itself. The firm leads rounds with initial check sizes of $500,000 to $10 million, typically acting as the first institutional capital provider. Notable portfolio companies include Merus (which had a successful IPO exit in May 2016), InteRNA Technologies, Sapreme Technologies, Inthera Bioscience, and Cristal Therapeutics. Aglaia's model of co-founding companies alongside its portfolio investments distinguishes it from conventional venture investors. By taking a driving role in product development from the earliest stages, the firm functions as both capital provider and operational partner — directly shaping scientific strategy, clinical prioritisation, and corporate formation in companies working to transform cancer treatment across Europe and North America.

AgriTech Hub is a pioneering venture capital fund based in Warsaw, Poland, dedicated to transforming the agricultural and food technology sectors across Central and Eastern Europe. Launched as the region's first VC fund with a specific focus on agri-tech, AgriTech Hub invests in early-stage companies that leverage cutting-edge technology and data analytics to address critical challenges in agriculture, food production, and sustainability. The fund's investment strategy targets innovative solutions in four primary areas: foodtech, waste-tech, bioenergy, and advanced sensors. In foodtech, AgriTech Hub is particularly interested in novel processing techniques, such as osmotic drying and food disinfection methods, which enhance product quality and safety. The waste-tech sector offers significant opportunities for managing food production waste and optimizing resource use, while the bioenergy focus supports projects that advance renewable energy through improved fermentation processes at biogas plants. Additionally, AgriTech Hub invests in IoT and advanced sensor technologies that improve agricultural efficiency by monitoring critical environmental factors. AgriTech Hub typically invests between $250,000 and $5 million, supporting companies from their inception through to early growth stages. The fund's portfolio includes notable investments like Agrivi, a leading farm management software provider, and FitAdept, a personalized fitness platform. These investments reflect the fund's commitment to driving technological advancements that contribute to a more sustainable and efficient agricultural sector. By backing startups that address global food and energy challenges, AgriTech Hub aims to create impactful, long-term solutions that benefit both the environment and the economy.

Agronomics is a London-listed investment firm leading the charge in cellular agriculture, a field focused on producing agricultural products directly from cell cultures rather than through traditional farming. This approach holds promise in addressing critical issues like climate change, deforestation, and food insecurity. Agronomics invests in ventures aiming to disrupt animal husbandry and conventional food production, focusing on meat, dairy, leather, and other products derived through cutting-edge biotechnology, precision fermentation, and tissue engineering. Their portfolio includes over 20 companies, such as Meatable, a cultivated meat firm specializing in pork and beef, and BlueNalu, which is developing cell-based seafood products. These startups are pioneering solutions to replace conventional protein sources with more sustainable alternatives, reducing environmental impact and improving food security. Agronomics typically targets early-stage investments, leveraging its expertise to support companies through technological and regulatory challenges. The firm invests globally, with a particular focus on the rapidly growing precision fermentation and cellular agriculture sectors. Their goal is to not only provide capital but also help drive regulatory approvals and scalability for sustainable food production. Led by co-founders Jim Mellon and Denham Eke, Agronomics offers a unique blend of financial and scientific insight. Their active approach includes deep involvement in company growth strategies, particularly around impact and sustainability metrics. This positions Agronomics as a leader in shaping the future of food technology.

Ahren Innovation Capital is a deep tech and science-focused investment firm, aiming to support transformational companies at the intersection of cutting-edge science and technology. With over $400 million in their latest fund, Ahren targets companies working in domains such as AI, genetics, robotics, and sustainable energy. They take an active role in nurturing early-stage to pre-IPO companies, focusing on ventures that have the potential to create new markets or disrupt existing ones. Ahren’s portfolio includes pioneering companies like Graphcore (AI hardware), Edifice Health (inflammatory disease diagnostics), and Meatable (cultivated meat). Their science partners include Nobel laureates and renowned scientists like Sir Gregory Winter and Lord Martin Rees, who bring deep expertise to the diligence process and ongoing business support. The firm has a strong network of strategic LPs, giving their portfolio access to key industry partners and customers. Led by Alice Newcombe-Ellis, Ahren's model blends visionary investment with commercial acumen, helping companies scale while maintaining a commitment to groundbreaking innovation. They prioritize building lasting relationships with founders, positioning themselves as trusted partners who contribute both capital and deep technical knowledge​.

AI Seed is a London-based venture capital firm that focuses on early-stage investments in artificial intelligence startups. Founded in 2017, it has built a reputation as one of the UK's leading AI funds, with a portfolio exceeding 40 companies. Notable investments include Odin Vision, Rahko, and Facesoft. AI Seed supports startups primarily in sectors such as healthcare, finance, and business software, aiming to invest in innovative AI applications with the potential for significant market disruption. The fund typically invests around £100,000 in each startup, seeking 5-10% equity and often leading the seed round. It also provides extensive mentorship and support, leveraging its network to help startups access AI talent, commercial partners, and growth opportunities. AI Seed’s leadership team, including Michael Axelgaard, Jacques de Cock, and Steve Weis, brings a wealth of experience from previous successful ventures, combining technical expertise with operational know-how. While primarily active in the UK, the fund maintains connections in Silicon Valley, offering startups valuable international exposure. AI Seed’s approach emphasizes hands-on involvement, from initial funding through to scaling, with a clear strategy to prepare startups for follow-on funding and growth. The fund’s emphasis on AI-specific solutions makes it a valuable partner for founders looking to innovate within this space.

African Infrastructure Investment Managers (AIIM) is a prominent private equity firm that focuses on investing in critical infrastructure projects across Sub-Saharan and North Africa. Established in 2000, AIIM is a wholly-owned subsidiary of Old Mutual Alternative Investments, one of Africa’s leading investment groups. The firm’s headquarters is in Cape Town, South Africa, with additional offices in Nigeria, Kenya, and Côte d'Ivoire, allowing it to have a deep understanding of the diverse African business environment. AIIM manages assets valued at approximately USD 2.8 billion and has a robust portfolio of over 74 infrastructure projects spanning various sectors, including energy, transport, telecommunications, and water. The firm’s investment philosophy is centered on long-term value creation, targeting projects that not only offer substantial financial returns but also contribute to the economic development and sustainability of the regions they serve. AIIM's track record includes managing several highly successful funds, such as the African Infrastructure Investment Fund (AIIF) series, which has been instrumental in financing large-scale infrastructure projects across the continent. These funds focus on sectors that are critical to Africa's growth, including renewable energy, where AIIM has made significant investments to help transition the continent to more sustainable energy sources. With a team of 44 investment professionals, AIIM brings extensive experience and sector-specific knowledge, ensuring that their investments are managed with the highest level of expertise. AIIM continues to play a vital role in driving Africa’s infrastructure development, helping to unlock economic potential and improve the quality of life for millions across the continent.

Air Liquide, a global leader in gases, technologies, and services for industry and healthcare, is deeply committed to advancing sustainability and innovation through its strategic plan, ADVANCE. This strategy, designed for 2025, integrates financial performance with sustainable development goals, focusing heavily on decarbonization and the growth of key future markets, such as hydrogen and electronics. The company plans to reduce its CO₂ emissions by one-third by 2035 and aims for carbon neutrality by 2050. To achieve these goals, Air Liquide is investing significantly, with approximately 50% of its industrial investments allocated to the energy transition, including hydrogen technologies. The company is also simplifying its organizational structure to enhance agility and performance, enabling quicker decision-making and better customer service. Air Liquide’s efforts in decarbonization are demonstrated by projects like the large-scale Cryocap™ CO₂ capture unit in Rotterdam and the development of a global hydrogen distribution network through partnerships like TEAL Mobility with TotalEnergies. With over 66,000 employees across 60 countries, Air Liquide continues to drive forward with its dual focus on growth and sustainability, positioning itself as a leader in the transition to a low-carbon economy​.

Air Street Capital is a leading venture capital firm focused on AI-first companies, headquartered in London. Founded by Nathan Benaich, the fund aims to back innovative startups leveraging artificial intelligence across various sectors, including life sciences, enterprise software, and consumer technology. The firm has made significant investments in notable companies such as Exscientia, a pharmaceutical company listed on NASDAQ; Graphcore, an AI semiconductors company acquired by SoftBank; and Intenseye, a workplace safety platform utilizing computer vision. Other prominent investments include Recursion, ZOE, and Stability AI. Air Street Capital's investment strategy involves early-stage funding, actively iterating on product and market strategies from day one. The fund's typical investment size ranges from seed to Series A rounds, ensuring substantial support for startups at their most critical stages of development. The firm emphasizes creating enduring companies with lasting market impact, guided by a rigorous, science-driven approach to investment. The team at Air Street Capital includes experts like Alex Chalmers and Paula Pastor, who bring extensive experience in legal, operations, and platform development. Their collective expertise and strategic insights help portfolio companies navigate complex challenges and scale effectively. With a robust portfolio and a clear focus on AI-driven innovation, Air Street Capital stands out as a pivotal player in the venture capital landscape, driving forward the capabilities and applications of artificial intelligence across industries​.

Airbridge Equity Partners is an Amsterdam-based venture capital firm founded in 2017, focusing on early-stage and growth-stage investments in technology-driven companies across Europe. The firm targets scalable ventures in both B2B and B2C sectors, particularly within the digital landscape. Airbridge is known for its flexible approach, offering equity investments, follow-on expansion capital, and venture debt, allowing them to support companies throughout their growth journey. In 2023, Airbridge closed its second fund, AEP-II, with a commitment of €63 million, marking a significant step in expanding its influence in the European tech ecosystem. The fund is distinguished by its inclusion of external Limited Partners (LPs) for the first time, some of whom are founders of companies that Airbridge previously backed. This reflects strong confidence in the firm’s strategic vision and investment expertise. Airbridge’s portfolio includes notable companies like Smartlook, Roam.ai, and Honey Sales. The firm's investment strategy is centered on building deep partnerships with ambitious management teams, leveraging their extensive sector knowledge to drive growth and innovation in the tech space.

Alabaster Co. is a publishing company founded in 2016 that blends creativity, beauty, and faith to create visually stunning editions of the Bible and other religious texts. The company was started by Brian Chung and Bryan Ye-Chung, who shared a vision of making the Bible more accessible and engaging, particularly in a world increasingly influenced by visual culture. Their beautifully designed Bibles integrate visual imagery with thoughtful design, transforming traditional biblical texts into artful experiences that resonate with modern readers. Alabaster's mission is to present the story of God as not only spiritually enriching but also aesthetically beautiful. This approach reflects their belief that beauty plays a crucial role in deepening one's connection with faith. The company's products are intended to invite readers into a deeper, more contemplative engagement with the Scriptures, helping them see the Bible in a new light. In addition to Bibles, Alabaster Co. has expanded its offerings to include devotionals, Bible studies, and other home goods, all designed with the same commitment to beauty and quality. Their work has sparked conversations about faith and beauty, making their products popular not just for personal use but also as conversation pieces in homes.

AlbionVC, founded in 1996 and based in London, is a leading venture capital firm that focuses on early-stage investments in B2B software, healthcare, and deep tech companies primarily in the UK. The firm manages around £1 billion in venture funds and supports companies from seed to Series B stages. Notable investments in AlbionVC's portfolio include Quantexa, a data and analytics company specializing in contextual decision intelligence; Oviva, which provides app-guided programs for changing dietary and lifestyle habits; and Phrasee, a brand language optimization solution. The firm has also seen successful exits, such as Orchard Therapeutics, which focuses on gene therapies for life-threatening diseases, and Egress Software, a provider of data security solutions. AlbionVC is known for its hands-on approach, providing long-term capital and expertise to help visionary founders scale their businesses. The firm's investment strategy is characterized by its deep sector knowledge and a strong focus on innovation and growth.

BioCity is a leading life sciences incubator and early-stage investor, renowned for its focus on nurturing innovative ventures within the UK’s vibrant biotech ecosystem. With hubs across Nottingham, Alderley Park, and Scotland, BioCity supports a wide array of startups, especially those pioneering breakthroughs in biotechnology, medical devices, and drug discovery. The fund typically invests between £50,000 to £250,000, targeting companies at the seed stage, often co-investing alongside industry giants like AstraZeneca and prominent angel investors. Notable investments include Maxwellia, a pioneer in converting prescription drugs to over-the-counter solutions, and NanoSyrinx, which is developing precision therapeutics. BioCity's strategic approach is sector-agnostic within life sciences, providing not just capital but also high-end laboratory space, business support, and access to a network of industry experts. The team is led by seasoned professionals, including Dr. Imelda Juniarsih, known for her keen eye in identifying high-potential early-stage ventures. While their primary geographic focus is the UK, they are open to opportunities that align with their mission of advancing life sciences innovation. Startups seeking investment are encouraged to engage early, as BioCity values deep, collaborative relationships with its portfolio companies, often built through long-term incubation and mentorship.

Aleph VC, founded in 2013 and based in Tel Aviv, is a prominent venture capital firm focused on early-stage investments in Israeli entrepreneurs. With $850 million under management, Aleph specializes in sectors such as fintech, digital health, cybersecurity, AI, and machine learning. The firm aims to build impactful global brands by providing strategic guidance and access to global markets. Notable investments in Aleph's portfolio include Lemonade, a global insurance company powered by AI and behavioral economics; Melio, which offers digital payment tools for small businesses; and Nexar, a dashcam and edge-AI platform for improved driving. Aleph has also backed companies like Freightos, a digital freight marketplace, and Placer.ai, a leader in location analytics. Aleph's investment strategy typically involves seed and early-stage funding, with investment sizes ranging from $2 million to $12 million. The firm has a strong track record of successful exits, including the public offerings of companies like Lemonade and Monday.com, and acquisitions such as Raftt by Wiz. The team at Aleph is led by co-founders Michael Eisenberg and Eden Shochat, along with partners Yael Elad and Tomer Diari. They leverage their extensive network and expertise to help portfolio companies grow and succeed on a global scale. Aleph's focus on innovation and strong support for its portfolio companies has established it as a leading venture capital firm in Israel​.

Alexandria Real Estate Equities, Inc. (NYSE: ARE) is a prominent real estate investment trust (REIT) specializing in collaborative life science campuses. Founded in 1994, Alexandria is a pioneering force in the life science real estate niche, owning, operating, and developing innovative campuses in major urban locations known for their scientific and technological advancements. The company's extensive portfolio spans key innovation clusters across North America, including Greater Boston, San Francisco Bay Area, San Diego, Seattle, Maryland, Research Triangle, and New York City. As of March 31, 2024, Alexandria's total market capitalization is $34.4 billion, with an asset base of 74.1 million square feet, which includes operating properties, properties under construction, and planned development projects. Alexandria's success is built on its proven cluster model, which integrates essential components such as strategic location, cutting-edge innovation, top-tier talent, and substantial capital. This model has allowed the company to create and nurture thriving life science ecosystems that facilitate groundbreaking research and development in fields such as biotechnology, pharmaceuticals, and agtech. In addition to real estate, Alexandria operates several strategic verticals, including Alexandria Venture Investments, which invests in disruptive life science companies, and a strong focus on corporate responsibility, promoting sustainability and social impact initiatives. The company's mission-driven approach and operational excellence make it a trusted partner for nearly 800 tenants, driving stable and resilient cash flows through high-quality, long-term leases with diverse tenants.

Alfvén & Didrikson is a Stockholm-based venture capital firm founded in 2010 by Hjalmar Didrikson and Måns Alfvén. The firm focuses on investing in fast-growing companies in Northern Europe, particularly in sectors like fintech, SaaS, software, healthcare, media, and entertainment. Their investment stages range from pre-seed to Series A. Notable investments by Alfvén & Didrikson include Trustly, Quinyx, Acast, Mentimeter, Sympa, and Airmee. These companies span various industries, from online payments and workforce management to podcast platforms and logistics​. The firm prides itself on being a long-term backer of passionate entrepreneurs and teams with international growth ambitions. They emphasize active ownership and aim to support companies in scaling and achieving significant market impact​.

LinkedIn, the world’s largest professional networking platform, has ventured into the startup and venture capital space through LinkedIn Ventures. As part of LinkedIn’s broader strategy to foster innovation, this venture capital arm invests in early-stage companies that align with LinkedIn’s mission of connecting professionals and making them more productive. LinkedIn Ventures is especially interested in startups focused on B2B technology, artificial intelligence, machine learning, and the future of work, all of which complement LinkedIn’s core business model. The venture arm aims to support innovative startups that can help accelerate LinkedIn’s long-term goals of expanding its product ecosystem and enhancing the overall user experience for its global network of professionals. By providing both capital and strategic resources, LinkedIn Ventures helps startups scale faster, offering them access to LinkedIn’s vast user base, data, and market insights. In addition to funding, LinkedIn offers its portfolio companies the opportunity to collaborate closely with its internal teams, providing mentorship, product development advice, and marketing support. This allows the startups to leverage LinkedIn’s expertise in scaling platforms and reaching professionals across the globe. The firm’s investments are often in alignment with LinkedIn’s long-term vision of shaping the future of professional networking, HR tech, and workforce solutions. LinkedIn Ventures has positioned itself as a key player in the venture capital landscape, supporting high-potential startups while reinforcing LinkedIn’s role as a leader in connecting the global workforce.

All Iron Ventures, rebranded as Acurio Ventures in September 2024, is a Bilbao, Spain-based venture firm founded in 2017 by Ander Michelena and Jon Uriarte, who previously co-founded Ticketbis and sold it to eBay in 2016 for $165 million. With approximately €300 million in assets under management across three funds — Fund I (€66 million), a €30 million fund of funds, and Fund III (€150 million, closed 2024) — the firm has backed more than 90 startups across Europe and the United States. The 12-person team operates from offices in Bilbao, Madrid, Barcelona, and London. Partners Diego Recondo, Hugo Mardomingo, and Kate Cornell complement the founding duo. All Iron leads rounds at seed and Series A stages, deploying $500,000 to $10 million per investment, and focuses on consumer and enterprise technology including marketplaces, SaaS, e-commerce, edtech, adtech, HR technology, and mobility. The portfolio carries an impressive track record: 4 unicorns and 8 acquisitions among 90 or more companies. Notable investments include Seedtag, Jobandtalent (unicorn), Lingokids, Preply, Refurbed, Lookiero, Lime, and Zum. The founding partners bring a distinct perspective as entrepreneurs-turned-investors — having scaled Ticketbis across multiple markets before a major exit, they understand the realities of building globally competitive businesses from Europe. This operator credibility shapes the firm's hands-on approach to working with founders on strategy, market expansion, and team development, and underpins a portfolio construction philosophy that favours conviction bets on founders reshaping large markets through technology.

Allegion Ventures is the corporate venture capital arm of Allegion, a Fortune 500 global leader in security products and solutions headquartered in Dublin, Ireland. Launched in March 2018 with a $50 million Fund I and subsequently expanded with a $100 million Fund II, the firm has deployed $150 million across two vehicles to invest in innovative technology and software bridging physical and digital security. President Rob Martens, who also serves as Allegion's Head of External Partnering and Global Futurist, leads the strategic direction, alongside Managing Director Bobby Prostko and Principal John Goodwin. Allegion Ventures targets seed through Series B investments with check sizes of $1 million to $15 million, focusing on IoT and data security, building analytics, construction lifecycle management, property management, and access control — sectors where the parent company has deep domain expertise. The portfolio of 19 companies includes Openpath (access control), HqO (workplace experience), Robin (workplace management), Pindrop (voice security), VergeSense (spatial intelligence), Ambient.ai (computer vision security), and Asylon (drone security). The fund is managed in partnership with Touchdown Ventures, which assists several Fortune 500 corporate VCs. Allegion Ventures backs solutions that make security and access smarter, stronger, faster, and less intrusive. Portfolio companies gain access to Allegion's global distribution channels, deep technology expertise in physical security, and an established customer base spanning commercial real estate, hospitality, healthcare, and institutional environments — advantages that create meaningful go-to-market acceleration for startups in the built environment security space.

AI2 Incubator, founded by Paul Allen's Allen Institute for AI, is a Seattle-based incubator focused on launching groundbreaking AI startups. With a mission to support AI-driven innovation, AI2 Incubator provides pre-seed investments of up to $500,000, access to $1M in cloud computing credits, and AI product development resources. Startups in its portfolio span critical areas like foundation models, AI for social good, and domain-specific AI. Some of their notable alumni include companies like Lexion, WhyLabs, and WellSaid Labs, with the incubator's startups collectively raising over $220 million. AI2 Incubator emphasizes hands-on involvement, supporting founders from ideation through Series A. It also offers extensive technical guidance, customer discovery assistance, and access to a network of AI experts. Founders from diverse backgrounds—engineers, scientists, product leaders—are encouraged to apply, with the incubator prioritizing teams that are passionate about solving real-world problems through AI. The incubator is led by a team of seasoned AI professionals, including Oren Etzioni and Jacob Colker, who work closely with startups to ensure their success in building innovative products and scaling their businesses. With deep ties to the AI2 research institute, AI2 Incubator helps startups leverage cutting-edge research to build impactful, scalable products. This unique combination of early capital, expert mentorship, and technical support has made AI2 Incubator a key player in fostering the next generation of AI-first companies.

Alliance Ventures is the strategic venture capital arm of the Renault-Nissan-Mitsubishi Alliance, one of the largest automotive groups globally. Launched in 2018, the fund focuses on investing in innovative startups that are transforming the future of mobility. With headquarters in Amsterdam and offices in key innovation hubs such as Silicon Valley, Paris, Yokohama, and Tel Aviv, Alliance Ventures targets early-stage companies developing technologies related to new mobility, autonomous driving, electric vehicles (EV), energy solutions, and connected services. The fund, with an initial capital of $200 million, primarily invests in Series A and B rounds, helping startups scale through strategic collaborations within the Alliance’s vast automotive ecosystem. Notable investments include companies like WeRide (autonomous driving in China), Enevate (battery technology), and The Mobility House (smart charging and energy storage). Alliance Ventures leverages its extensive network to provide not only capital but also partnerships and market access to accelerate startup growth. Led by a seasoned team, including General Secretary Véronique Sarlat-Depotte and Partner Ryan Armbrust, the fund actively supports startups through every growth phase, from early innovation to commercial scaling, aiming to integrate cutting-edge solutions into the Renault-Nissan-Mitsubishi operations.

Allianz, a global leader in insurance and asset management, operates through two main investment arms: Allianz Global Investors and Allianz Capital Partners. Together, they manage over €2.5 trillion in assets across diverse markets. Allianz's investment strategy focuses on generating long-term value, with a commitment to sustainability. They lead in sectors like infrastructure, renewable energy, and private equity, emphasizing a "buy and hold" approach for stability. Their investments prioritize both developed markets and key emerging areas, with notable portfolios in infrastructure and private markets, such as wind and solar energy projects, which provide consistent returns. Allianz aims to reduce market volatility risks through diversification, and their sustainable investment efforts are core to their strategy, contributing to net-zero targets. With a presence in over 70 countries, Allianz targets opportunities worldwide, emphasizing sustainable and scalable growth models. Allianz Global Investors and Capital Partners work across public and private markets, helping clients meet evolving investment goals by blending traditional assets with alternatives like private equity and renewables.

Allianz X, the digital investment arm of Allianz Group, focuses on investing in digital growth companies relevant to insurance and asset management. Since its inception, Allianz X has grown its portfolio to over 25 companies with assets under management exceeding €2 billion. The firm has identified 12 unicorns within its portfolio, showcasing its strategic investment acumen. Headquartered in Munich, Allianz X supports companies primarily in the insurtech and fintech sectors, aiming to foster innovations that complement Allianz Group's core businesses. Their investment approach includes late-stage funding, helping mature companies reach their next growth milestones. Key portfolio companies include WeLab, a leading digital financial service provider in Asia, and Pie Insurance, a digital provider of workers' compensation insurance in the U.S. Allianz X has been involved in significant funding rounds, such as co-leading a $250 million Series F investment in Coalition, Inc., a cyber insurtech company, and leading funding for London-based fintech OpenGamma. Their strategy also includes facilitating collaborative partnerships within the digital ecosystem to drive innovation and growth​.

Almaz Capital is a venture capital firm founded in 2008 by Alexander Galitsky, focusing on early-stage technology startups with global market potential. With offices in Silicon Valley and Berlin, Almaz Capital bridges entrepreneurial talent from Central and Eastern Europe (CEE) and the Commonwealth of Independent States (CIS) with global markets. The firm has invested in notable companies like Acumatica, Vyatta, Parallels, and EverNote. The firm targets sectors such as Internet Infrastructure, Software, Artificial Intelligence, and Internet of Things (IoT). They are known for supporting companies through various growth stages, providing not just capital but also strategic guidance, industry connections, and operational support. Almaz Capital is committed to fostering innovation and scalability in its portfolio companies. Key team members include Alexander Galitsky (Co-Founder and Managing Partner), Charles E. Ryan (General Partner), and Geoffrey Baehr (General Partner). The team brings extensive experience in global business operations and investment, helping startups achieve significant growth and market reach.

Almi Invest is Sweden's most active early-stage venture capital firm, focusing on investing in startups across various sectors, including technology, life sciences, industry, and cleantech. As part of the state-owned Almi Group, Almi Invest operates through eight regional funds and a specialized national GreenTech fund, which targets climate-smart investments that contribute to CO2 reduction. The firm has recently raised €140 million (approximately SEK 1.6 billion) for its third investment fund, which will be deployed from 2024 to 2029. This fund aims to support around 300 startups, continuing Almi's tradition of nurturing early-stage companies across Sweden. Over its history, Almi Invest has backed nearly a thousand companies, achieving over 600 successful exits. This track record has established the firm as a cornerstone of Sweden's startup ecosystem, with many portfolio companies eventually being acquired by global giants like Google, Microsoft, and Apple. Almi Invest's regional presence is critical to its strategy, ensuring that startups throughout Sweden have access to the capital and support they need to grow. The firm’s focus on sustainability and innovation aligns with Sweden’s broader goals of fostering a vibrant, future-oriented economy.

AI Capital is a venture capital firm based in Denver, with operations spanning North America, Europe, and Asia. It focuses on early-stage investments in AI-driven companies, particularly in enterprise software and data platforms. The firm’s primary industry targets are healthcare, life sciences, and core industries like energy and manufacturing, where AI can optimize supply chains and critical services. Additionally, AI Capital invests heavily in cybersecurity, recognizing its importance across these sectors. The firm typically invests in Seed to Series B rounds, bringing a strong combination of technical expertise and deep investment experience. Recent notable portfolio companies include Link3D, Syndesis Health, and Luminoso. AI Capital emphasizes transformative AI applications, from VR therapy to advanced genomic solutions. They aim to support companies with high growth potential and significant societal impact. The firm is led by experienced partners like Neville Teagarden and Andrew Maus, with a team composed of AI specialists and seasoned investors. They value companies solving real-world problems through breakthrough AI technologies. AI Capital often leads rounds and is known for being highly involved with its portfolio companies, offering both strategic and operational support. Founders are encouraged to approach them through established networks or referrals, particularly those innovating in AI's frontier sectors.

Alpine VC targets founders who are relentless about their products and users, focusing on companies in consumer tech, prosumer software (including tools for creators and developers), and software designed for SMBs. Alpine prioritizes product-led growth (PLG) startups and seeks companies whose products directly resonate with and serve their customers effectively. With typical check sizes from $250,000 to $1 million, they invest at the seed and Series A stages, comfortable leading, co-leading, or joining larger syndicates for flexible collaboration. Alpine operates globally but is rooted in Alameda, California. They emphasize founder passion over traditional metrics like education or professional background, valuing founders who live and breathe their products and who demonstrate an unwavering commitment to the user experience. Alpine’s strategy revolves around building strong, supportive relationships with founders, aiding in everything from go-to-market strategies to operational scaling and customer engagement. The Alpine team is known for its user-centered investment approach, thinking from the perspective of the end user to drive meaningful product development. They encourage founders to pitch directly, favoring those with a clear vision, deep product insights, and a strong connection to their target market. This lean, founder-focused approach allows Alpine to spot high-potential opportunities and help guide early-stage companies through pivotal growth stages, making Alpine an ideal partner for innovative, product-driven startups seeking flexible, strategic support.

Altalurra Ventures is an impact-driven, technology-focused venture capital fund based in Rye, New York, founded in 2022. The firm's mission is to support technology startups that demonstrate measurable positive impact alongside sustainable business models, investing at pre-seed, seed, and Series A stages across North America and opportunistically into Europe, Israel, and Latin America. Altalurra is named to the ImpactAssets 50, a recognised benchmark of impact fund managers worldwide, reflecting its standing within the responsible investment community. The firm deploys $250,000 to $1 million per investment across climate technology, industry technology, infrastructure technology, and social impact technology, and leads rounds. Its six-person team — including three partners — has built a portfolio of 5 companies including Suma (financial services), 4Earth (alternative energy), 50inTech (diversity-focused human capital), and Impak Analytics, whose $4.33 million Series A Altalurra led alongside Société Générale. Altalurra's investment thesis is rooted in the conviction that the most durable businesses of the next decade will be those that generate financial returns and measurable social or environmental value simultaneously. The fund's broad international footprint — spanning the US, Canada, Brazil, Mexico, Israel, and much of Western Europe — reflects a belief that the most important impact-positive companies will emerge across geographies rather than from a single hub. Founders at the intersection of technology and sustainability will find in Altalurra a capital partner with genuine conviction around both the commercial and impact dimensions of their business.

Altamira is a Warsaw-based venture capital firm focused on investing in early-stage companies that develop innovative, practical technologies in industries like pharmaceuticals, medical devices, and industrial production. The firm actively collaborates with founders, investing not just capital but also expertise and strategic resources to help them achieve breakthroughs in international markets. Altamira targets fields where new technologies can be applied in physical realities rather than virtual ones. Their investment focus covers sectors like Internet of Things (IoT), clean tech, smart buildings, and recycling. The firm’s approach is rooted in establishing strong partnerships with ambitious teams, aiming to develop solutions with significant global revenue potential. With an average round size of around $6 million, Altamira plays an active role in supporting the companies it invests in, fostering long-term growth through continuous engagement and follow-on investments.

Alter Equity, based in Paris, is a pioneering impact investment firm founded by Fanny Picard. The firm focuses on companies that provide solutions to environmental and social challenges, adhering to an ESG-driven model that prioritizes sustainable growth. Launched in 2013, Alter Equity’s investment strategy revolves around supporting European companies with a strong focus on sectors such as renewable energy, circular economy, green chemistry, education, and well-being. They typically invest between €3 million and €10 million in companies with annual revenues above €800,000 that demonstrate strong growth potential. The firm’s portfolio includes companies like Teale, a mental health platform, Beem, which provides photovoltaic kits, and Neobrain, a human resources tech company focusing on employment management and skills development. Alter Equity is particularly committed to gender diversity, with 33% of its portfolio companies led by women, one of the highest rates in French private equity. Alter Equity stands out for its measurable impact. Its portfolio companies have collectively saved 6.8 million tons of CO2 since the firm's inception, aligning with its mission to contribute to both social and environmental sustainability.

Alven, founded in 2000 by Guillaume Aubin and Charles Letourneur, is a leading venture capital firm based in Paris with a strong focus on early-stage investments. The firm recently closed its sixth fund at €350 million, the largest early-stage fund raised in France, bringing their assets under management to €2 billion. Alven specializes in backing European entrepreneurs, with notable investments in companies like Qonto, Dataiku, Algolia, Stripe, and Ankorstore. The firm’s strategy includes investing between €100k and €15 million in seed and Series A rounds, with substantial reserves for follow-on investments. Alven supports its portfolio companies with an internal People Operations team, offering advisory services, access to talent pools, and resources to help them scale. The firm emphasizes a multi-sector specialist approach, focusing on fintech, marketplaces, enterprise software, social & entertainment, and emerging sectors like crypto and climate tech. Alven has realized more than 70 exits, including the recent sales of Sqreen to Datadog, Cardiologs to Philips, and Frichti to Gorillas. They recently expanded their geographic focus by opening a London office and continue to support European founders in the US. For startups looking to engage with Alven, it's crucial to demonstrate a strong growth potential and alignment with the firm’s commitment to long-term relationships and hands-on support​.

AM Ventures is a leading venture capital firm focused on the industrial 3D printing sector, also known as additive manufacturing. Established in Germany, AM Ventures supports early-stage startups worldwide that are innovating in areas such as materials, software, hardware, and applications related to 3D printing. The firm is renowned for its deep industry expertise and extensive global network, which spans 13 countries across four continents. The firm’s investment strategy is centered on empowering entrepreneurs who are developing next-generation technologies that can address major global challenges, including climate change, medical advancements, and digital manufacturing. AM Ventures typically invests between €500,000 and €3 million, focusing on companies from the seed stage to growth phases. In 2022, AM Ventures launched a €100 million venture capital fund dedicated to furthering its commitment to industrial 3D printing. This fund is the first of its kind, emphasizing the firm’s leadership in the additive manufacturing industry and its dedication to driving sustainable innovation on a global scale. The firm partners closely with its portfolio companies, offering not just financial backing but also strategic support and industry connections to help these startups thrive.

Amadeus Capital Partners, founded by Anne Glover and Hermann Hauser in 1997, is a renowned global technology investor. The firm has backed over 190 companies and raised more than $1 billion in investment capital. They focus on AI and machine learning, online consumer services, cyber security, digital health and medical technology, digital media, enterprise SaaS, fintech, regtech, and insurtech. Notable investments in their portfolio include Graphcore, FiveAI, Congenica, Sprout.ai, and Seldon. Amadeus follows a multi-faceted investment strategy: providing seed, start-up, and scale-up capital for early-stage companies in the UK, primary and secondary investments in high-growth tech companies in Europe, and growth capital for tech-enabled consumer and business services in emerging markets. They typically invest in companies with exceptional IP that have the potential to become global champions. With offices in Cambridge, London, San Francisco, and Cape Town, Amadeus Capital Partners supports scaling businesses with technical insight, operational experience, and access to a global network, including mentorship and non-executive directors. Their recent £110 million Amadeus V Technology Fund highlights their commitment to deep tech investment, with significant backing from British Patient Capital. Amadeus prefers to invest in companies that demonstrate a strong team, competitive edge, and the potential for global market impact. Founders should approach them with a well-articulated market opportunity and technological innovation to capture their interest.

Amadeus Capital Partners is a prominent global venture capital firm based in London, established in 1997 by Anne Glover and Hermann Hauser. The firm has built a strong reputation for investing in high-growth technology companies across various sectors, including artificial intelligence, cybersecurity, digital health, fintech, and semiconductors. Amadeus Capital Partners focuses on different stages of investment, providing seed, early-stage, and growth capital to companies with the potential to become global leaders. They are particularly interested in businesses with innovative intellectual property (IP) and those addressing significant, underserved market needs. The firm supports its portfolio companies with both capital and strategic guidance, aiming to build companies that can expand globally. Some of the notable investments include companies like Riverlane, which focuses on quantum computing, and Graphcore, known for its AI hardware solutions. Amadeus Capital Partners has made over 340 investments and has successfully exited over 110 companies, including high-profile exits such as Lumeon and Brytlyt. The firm’s investment approach emphasizes backing great teams, fostering innovation in billion-dollar markets, and scaling businesses to achieve global impact. With a team of over 40 professionals and a strong network of co-investors, Amadeus continues to be a significant player in the venture capital landscape, driving technological advancements across various industries​.

Amavi Capital is a specialized investment firm based in Belgium, focusing on the PropTech sector across Europe. As one of the early movers in this space, Amavi Capital distinguishes itself by bridging the gap between traditional real estate industries and innovative PropTech companies. They primarily target scale-ups with proven market fit rather than startups, providing growth capital to help these companies expand. Their investments are characterized by a strong emphasis on sustainability, operational efficiencies, and technological innovation within the real estate sector. The firm typically invests between €0.5 million and €9 million per portfolio company, with a total target fund size of €60 million. They have already completed significant investments in various European countries, including companies like Shayp (Belgium), Finch Buildings (Netherlands), and Gbuilder (Finland). Amavi Capital also integrates ESG considerations into their investment decision-making process, although they do not fully adhere to all SFDR requirements due to resource constraints. Despite this, they focus on mitigating sustainability risks and influencing portfolio companies to adopt more sustainable practices.

The Amazon Industrial Innovation Fund (AIIF) is Amazon’s $1 billion venture fund focused on advancing technologies that reshape fulfillment, logistics, and supply chain sectors. Established in 2022, the fund invests in companies across various stages, from startups to established players, that bring innovative solutions to areas like warehouse automation, robotics, and artificial intelligence. AIIF's goal is to enhance Amazon’s operations, with an emphasis on employee safety, efficiency, and customer satisfaction. Under the leadership of Franziska Bossart, the fund is expanding its scope in 2024 to target additional areas such as autonomous vehicles and last-mile delivery tech. Key investments have included companies like Agility Robotics, which develops bi-pedal robots for warehouse operations, and Vimaan, specializing in computer vision for inventory management. AIIF’s investments in companies such as Modjoul, which creates wearable safety devices, highlight its commitment to fostering technologies that support workplace safety while advancing automation. AIIF aims to support high-quality companies globally, not limited to Amazon's internal needs, as it seeks broader improvements in industrial automation and supply chain management. This makes AIIF a significant player in the field of corporate venture capital, uniquely positioned to drive impactful innovations while improving Amazon’s logistics capabilities and operational safety.

Amdocs Ventures is the corporate venture arm of Amdocs (NASDAQ: DOX), a leading provider of software and services to communications and media companies worldwide, with $4.5 billion or more in annual revenue and 30,000 or more employees. Founded in 2018 and headquartered in Saint Louis, Missouri, the fund operates as a thesis-led investing vehicle — going deep in defined focus areas to develop genuine subject matter expertise in industries with disruptive potential. Unlike traditional venture capital, Amdocs Ventures prioritises investment in companies whose products supplement, integrate with, or expand Amdocs' own offerings within the telecommunications and media ecosystem. The fund deploys $1 million to $10 million per investment at seed through Series B stages, with a portfolio of 9 companies to date including Senser, illumex.ai (invested June 2024), and Flow Security. Focus areas include communications and messaging technology, AI and machine learning, software applications, data analytics, and cybersecurity — all domains where the parent company's customer relationships and technical infrastructure create strategic context for portfolio companies. Startups that partner with Amdocs Ventures gain access to the parent company's global telecommunications customer base, technology integration pathways, and commercial distribution across an industry that is actively modernising its software stack. The fund's presence in both the United States and Israel reflects the geographic depth of Amdocs' own operations and the talent ecosystems that are most relevant to its core telecom and media software focus.

Amgen Ventures is the corporate venture capital arm of Amgen Inc. (NASDAQ: AMGN), one of the world's largest biotechnology companies. Founded in 2004 and based in San Francisco — with additional offices in Seattle, Thousand Oaks, and Cambridge — the fund has invested over $1 billion across its 20-year history, backing early and later-stage biotech companies developing human therapeutics. Core therapeutic focus areas include oncology, inflammation, neuroscience, and cardiovascular disease. The fund deploys $2 to $3 million per transaction, with investments reaching up to $10 million per company across Seed through Series B rounds. With 80 investments spanning North America and Europe, Amgen Ventures supports novel modalities, platform technologies, and digital health solutions. The portfolio is led by Samantha Palmer, Executive Director and Head of Amgen Ventures, who was named to the 2024 Powerlist of 100 leading corporate venturing professionals. Amgen Ventures occupies a distinctive position in corporate venture: portfolio companies gain direct access to Amgen's extensive research capabilities, manufacturing infrastructure, and scientific expertise. In return, Amgen gains early visibility into external innovation across emerging therapeutic areas. This mutual exchange — strategic access for capital — underpins the fund's model, making it more than a financial investor and a genuine partner in building the next generation of biotech companies.

Ananda Impact Ventures, established in 2009, is a leading European venture capital firm dedicated to impact investing. The firm operates primarily in the DACH region, the UK, Benelux, and Scandinavia, focusing on early-stage investments from Seed to Series A rounds. Ananda manages around €200 million in assets across multiple funds, including their latest €108 million fund launched in 2023. Ananda invests in companies that address significant social and environmental challenges, aligning their business models with the UN’s Sustainable Development Goals. Their portfolio includes companies like OroraTech, which uses satellite technology to monitor wildfires, and NatureMetrics, which provides biodiversity data solutions through eDNA technology. The firm's investment strategy is built on their unique Impact Termsheet, which ties financial success to measurable impact outcomes. This model ensures that the impact is integral to the business, fostering long-term sustainability and growth. Ananda also emphasizes diversity and founder health, supporting entrepreneurs with robust resources and a hands-on approach to partnership. Founders appreciate Ananda's supportive and mission-aligned investment approach, which combines financial backing with strategic guidance to help scale impactful innovations. The firm prides itself on its deep commitment to creating positive societal change through venture capital.

Andera Partners, established in 2001 and headquartered in Paris, is a prominent private equity firm specializing in investments in life sciences, growth capital, and buyouts. The firm has built a strong reputation for its expertise in supporting companies at various development stages, particularly within the biotech and medical technology sectors. One of Andera's flagship initiatives is the BioDiscovery fund family, which has collectively raised over €1.1 billion to date. Their latest fund, BioDiscovery 6, closed at €456 million, highlighting significant investor confidence. This fund targets innovative therapeutic products and medical technologies, investing in companies across Europe and the United States. Notable investments include companies like Evommune, Amolyt, and TargED. Andera Partners employs a hands-on approach, providing both financial and strategic support to its portfolio companies. The firm's life sciences team, comprising experienced professionals like Sofia Ioannidou, Olivier Litzka, and Gilles Nobécourt, plays a crucial role in guiding startups from the preclinical stages to commercialization. Their strategic partnerships and extensive network bolster their ability to support high-potential innovations.

Angel Invest is a Berlin-based super angel fund and one of the most active early-stage investors in Europe, founded in 2017. Deploying approximately €125K per deal, the fund invests in roughly 100 startups per year across software, fintech, AI, e-commerce, healthtech, and clean technology. With 230 portfolio companies that have collectively raised over €2 billion in follow-on funding and carry a combined market capitalization exceeding €4 billion, Angel Invest has established a record of high-volume, high-conviction investing at the pre-seed and seed stages. Beyond capital, the fund provides each portfolio company with at least one year of active coaching. It has also built the Angel Invest Perks Platform, offering up to €4 million in curated credits, discounts, and partner access to support early operations. In 2025, the firm co-founded the Technology Briefing Center (TBC) in Berlin alongside Signal Iduna, an initiative analyzing AI, fintech, and climate tech trends to bridge innovation and strategic decision-making. Angel Invest's model deliberately prioritizes breadth and speed at the earliest stage — writing small checks quickly across a wide range of sectors and geographies within Europe. The fund's coaching commitment distinguishes it from passive micro-VCs: founders receive structured support during their first year, when operational guidance carries the most leverage. The combination of volume, mentorship infrastructure, and a growing perks platform creates compounding value across the portfolio.